Picture of The Chemours logo

CC — The Chemours News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsAdventurousMid CapContrarian

Brief: Chemours Outlook FY Adjusted EBITDA Between $825 Million And $975 Million

Feb 18 (Reuters) - Chemours Co  CC.N :
    * CHEMOURS: OUTLOOK FY ADJUSTED EBITDA BETWEEN $825 MILLION
AND
$975 MILLION
    * CHEMOURS: OUTLOOK FY CAPITAL EXPENDITURES BETWEEN $250
MILLION
TO $300 MILLION
    * CHEMOURS: OUTLOOK Q1 CONSOLIDATED NET SALES TO BE FLAT TO
SLIGHTLY DOWN SEQUENTIALLY
    * CHEMOURS: QTRLY NET SALES OF $1.4 BILLION
    * CHEMOURS: QTRLY ADJUSTED EPS $0.11
    * CHEMOURS: IN 2024, FULLY REMEDIATED ALL FOUR MATERIAL
WEAKNESSES
IN INTERNAL CONTROL PREVIOUSLY IDENTIFIED IN THE 2023 FORM 10-K
    * Q4 EARNINGS PER SHARE VIEW $0.12, REVENUE VIEW $1.36
BILLION --
LSEG IBES DATA
    * Q1 REVENUE VIEW $1.41 BILLION -- LSEG IBES DATA

Source text:  ID:nBwb2qq3ha 
Further company coverage:  CC.N 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on The Chemours

See all news